$$$$$$$$$$$$Gardasil Sales Decline – Victim of its Own Success

Found this great comment in an article written by Tracy Staton on the FiercePharma.com blog this morning. The politics of the HPV vaccine issue and the profiteering never ceases to amaze me.

“Let’s see. Merck is in the catbird seat on this one; as the sole HPV shot available in the U.S. to date–one with a major marketing blitz behind it–it’s fully entrenched in the market. Even so, the drugmaker has watched sales decline and decline, for a variety of reasons. Partly, Gardasil has been a victim of its own success, because as more and more girls and young women complete their three-shot series, the pool of unvaccinated females shrinks. To grow that market Merck has been looking for broader Gardasil use–in older women and in boys.”

PG

Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.